Lung involvement in inflammatory bowel diseases

Sarıoğlu, Nurhan; Türkel, Nurten; Şakar, Ayşın; Çeli̇k, Pınar; Saruç, Murat; Ma, Dongrui; Göktan, Cihan; Kırmaz, Cengiz; Yüceyar, Hakan; Yorgancıoğlu, Arzu

doi:10.5144/0256-4947.2006.407

Cited by 6 publications

(5 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A later study reported the prevalence of abnormal PFT to be as high as 39% in UC and 45% in CD [13]. Songur et al [8] reported abnormal CT and PFT in more than 50% of patients with IBD (Table 1) [13][14][15]. In an Indian study that looked at pulmonary and hematologic abnormality in 51 patients with IBD, 14 (27%) patients had abnormal PFT [16], similar to our findings.…”

Section: Discussionsupporting

confidence: 92%

“…Twenty-two per cent of the patients had abnormal HRCT. This prevalence is less than in earlier studies (22% to 88%), but the pattern of abnormalities is similar to that in earlier reports [8,14,15,17]. The HRCT abnormalities reported in IBD include bronchiectasis, air trapping, tree-in-bud appearance (branching pattern of small nodules), ground-glass appearance, peribronchial thickening and reticular pattern.…”

Section: Discussionsupporting

confidence: 80%

“…Three earlier studies reported higher prevalence of symptoms (44%, 23%, and 25.6%) [10,15,17]. We suspect that the small number of patients with symptoms in our study could be due to intermittent steroid use, although we do not have supporting data.…”

Section: Discussioncontrasting

confidence: 64%

See 2 more Smart Citations

Pulmonary manifestations in inflammatory bowel disease: a prospective study

Desai

Patil

Udwadia

et al. 2011

Indian J Gastroenterol

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionsupporting

confidence: 80%

See 1 more Smart Citation

Pulmonary manifestations in inflammatory bowel disease: a prospective study

Desai

Patil

Udwadia

et al. 2011

Indian J Gastroenterol

View full text Add to dashboard Cite

show abstract

Section: Incidence Of Respiratory Diseases (Rd) In Ibd and Of Ibd In supporting

confidence: 79%

Respiratory involvement in inflammatory bowel diseases

D'Andrea

Vigliarolo

Sanguinetti

2010

Multidiscip Respir Med

View full text Add to dashboard Cite

Inflammatory bowel diseases (IBD) include ulcerative colitis (UC) and Crohn's disease (CD) and are due to a dysregulation of the antimicrobial defense normally provided by the intestinal mucosa. This inflammatory process may extend outside the bowel to many organs and also to the respiratory tract. The respiratory involvement in IBD may be completely asymptomatic and detected only at lung function assessment, or it may present as bronchial disease or lung parenchymal alterations. Corticosteroids, both systemic and aerosolized, are the mainstay of the therapeutical approach, while antibiotics must be also administered in the case of infectious and suppurative processes, whose sequels sometimes require surgical intervention. The relatively high incidence of bronchopulmonary complications in IBD suggests the need for a careful investigation of these patients in order to detect a possible respiratory involvement, even when they are asymptomatic.

show abstract

“…In fact, an abnormal percentage of alveolar lymphocytes was observed in 11 of 18 patients (61%) with a T-lymphocyte prevalence. The same was found by Sarioglou et al at the BAL fluid examination, where a lymphocytic alveolitis was evident in 46.6% of IBD cases [34]. A number of clinical lung diseases can be found in the course of IBD, but the true frequency of these conditions is unknown [19], although it has been shown that the incidence is higher in patients with UC than in those with CD (35).…”

Section: Incidence Of Respiratory Diseases (Rd) In Ibd and Of Ibd In Rdmentioning

confidence: 56%

Respiratory involvement in inflammatory bowel diseases

2010

View full text Add to dashboard Cite

Inflammatory bowel diseases (IBD) include ulcerative colitis (UC) and Crohn’s disease (CD) and are due to a dysregulation of the antimicrobial defense normally provided by the intes- tinal mucosa. This inflammatory process may extend outside the bowel to many organs and also to the respiratory tract. The respiratory involvement in IBD may be completely asymptomatic and detected only at lung function assess- ment, or it may present as bronchial disease or lung parenchymal alterations. Corticosteroids, both systemic and aerosolized, are the mainstay of the therapeutical approach, while antibiotics must be also administered in the case of infectious and suppurative processes, whose sequels some- times require surgical intervention. The relatively high inci- dence of bronchopulmonary complications in IBD suggests the need for a careful investigation of these patients in order to detect a possible respiratory involvement, even when they are asymptomatic.

show abstract

Lung involvement in inflammatory bowel diseases

Cited by 6 publications

References 15 publications

Pulmonary manifestations in inflammatory bowel disease: a prospective study

Pulmonary manifestations in inflammatory bowel disease: a prospective study

Respiratory involvement in inflammatory bowel diseases

Respiratory involvement in inflammatory bowel diseases

Contact Info

Product

Resources

About